{"id":"https://openalex.org/W56276121","doi":null,"title":"Effectiveness of mirtazapine in the treatment of depression with associated somatic symptoms.","display_name":"Effectiveness of mirtazapine in the treatment of depression with associated somatic symptoms.","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W56276121","mag":"56276121","pmid":"https://pubmed.ncbi.nlm.nih.gov/18286397"},"language":"en","primary_location":{"id":"pmh:oai:actaspsiquiatria.es:article/933","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/933","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/933/1493","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},"parent_works":[],"lineage":["https://openalex.org/W56276121"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://actaspsiquiatria.es/index.php/actas/article/download/933/1493","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011527705","display_name":"Javier Garc\u00eda\u2010Campayo","orcid":"https://orcid.org/0000-0002-3797-4218","observed_orcids":["https://orcid.org/0000-0002-3797-4218"]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"J Garc\u00eda Campayo","raw_affiliation_strings":["Hospital Miguel Servet, University of Zaragoza, Zaragoza, Spain. jgarcamp@arrakis.es"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Miguel Servet, University of Zaragoza, Zaragoza, Spain. jgarcamp@arrakis.es","institution_ids":["https://openalex.org/I255234318","https://openalex.org/I4210114530"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5011527705"],"corresponding_institution_ids":["https://openalex.org/I255234318","https://openalex.org/I4210114530"],"apc_list":null,"apc_paid":null,"fwci":0.4559,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.66600977,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"36","issue":"1","first_page":"25","last_page":"32"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11334","display_name":"Psychosomatic Disorders and Their Treatments","score":0.02329999953508377,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":1.0},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8339999914169312},{"id":"https://openalex.org/keywords/somatic-symptoms","display_name":"somatic symptoms","score":0.9980000257492065},{"id":"https://openalex.org/keywords/somatization","display_name":"somatization","score":0.9539999961853027},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/benzodiazepine-use","display_name":"benzodiazepine use","score":0.847000002861023},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.7850000262260437},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.7762711644172668},{"id":"https://openalex.org/C2777198177","wikidata":"https://www.wikidata.org/wiki/Q3765927","display_name":"Hamd","level":3,"score":0.6220069527626038},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5456907153129578},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5288665890693665},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4306654632091522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42595359683036804},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.0928015410900116},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000078785","descriptor_name":"Mirtazapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013001","descriptor_name":"Somatoform Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D013001","descriptor_name":"Somatoform Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmh:oai:actaspsiquiatria.es:article/933","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/933","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/933/1493","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:18286397","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18286397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas espanolas de psiquiatria","raw_type":"Journal Article"},{"id":"mag:56276121","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18286397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:actaspsiquiatria.es:article/933","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/933","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/933/1493","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W56276121.pdf","grobid_xml":"https://content.openalex.org/works/W56276121.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1971711167","https://openalex.org/W2002526542","https://openalex.org/W2010069094","https://openalex.org/W2018460312","https://openalex.org/W2025854834","https://openalex.org/W2061378977","https://openalex.org/W2079189663","https://openalex.org/W2081042060","https://openalex.org/W2082452224","https://openalex.org/W2086907721","https://openalex.org/W2101333063","https://openalex.org/W2107160549","https://openalex.org/W2167872714","https://openalex.org/W2167885570","https://openalex.org/W2313498130","https://openalex.org/W2417305709","https://openalex.org/W2469938013"],"related_works":["https://openalex.org/W2083948405","https://openalex.org/W2372907378","https://openalex.org/W2353978954","https://openalex.org/W2364709606","https://openalex.org/W2354830928","https://openalex.org/W2418007528","https://openalex.org/W2069151316","https://openalex.org/W2366435330","https://openalex.org/W2343888498"],"abstract_inverted_index":{"INTRODUCTION:":[0],"A":[1],"assess":[2],"the":[3,8,85,107,130,154,160,163,173,185,188,206],"efficacy":[4],"of":[5,10,74,95,119,129,153,162,172,179,184,208,219],"mirtazapine":[6],"in":[7,15,36,84,106,122,124,222],"treatment":[9,207],"depression":[11,75,209],"with":[12,210],"somatic":[13,57,96,120,133,211,220],"symptoms":[14,58,97,121,134,212,221],"a":[16,136],"3-months":[17],"follow-up":[18],"study.":[19,28],"DESIGN:":[20],"multicenter,":[21],"prospective,":[22],"observational,":[23],"open-label,":[24],"and":[25,32,51,64,68,202,213],"non":[26],"controlled":[27],"SAMPLE:":[29],"seven":[30],"hundred":[31],"eleven":[33],"patients":[34,174],"recruited":[35],"outpatient":[37],"psychiatric":[38],"consultations":[39],"by":[40,77,99],"98":[41],"psychiatrists":[42],"nationwide.":[43],"INSTRUMENTS:":[44],"17-Item":[45],"Hamilton":[46],"Depression":[47],"Rating":[48],"Scale":[49],"(HAMD-17)":[50],"Standardized":[52],"Polyvalent":[53],"Psychiatric":[54],"Interview":[55],"(SPPI),":[56],"section.":[59],"Patients":[60],"were":[61,192],"assessed":[62,76,98],"pretreatment":[63,86,125],"at":[65,90,112,140,159,166],"15,":[66],"30":[67],"90":[69],"days":[70],"post-treatment.":[71,93,115],"RESULTS:":[72],"Severity":[73,94],"HAMD-17":[78],"significantly":[79,101,146],"decreased":[80,102],"(p<0.0001)":[81,103],"from":[82,104],"23.27":[83],"assessment":[87,109],"to":[88,110,135,149,194,216],"6.75":[89],"3":[91,113,141,167],"months":[92,114,142,168],"EPEP":[100],"7.68":[105],"pre-treatment":[108],"2.28":[111],"Mirtazapine":[116,198],"modifies":[117],"attribution":[118,218],"somatizers:":[123],"assessment,":[126],"41.3":[127],"%":[128],"sample":[131,155],"attributed":[132],"psychological":[137],"origin,":[138],"while":[139],"post-treatment":[143,169],"this":[144],"percentage":[145],"increased":[147],"(p<0.05)":[148],"63.94%.":[150],"Nearly":[151],"half":[152],"(48.52%)":[156],"took":[157],"benzodiazepines":[158],"start":[161],"study;":[164],"but":[165],"only":[170],"6.71%":[171],"needed":[175],"them.":[176],"The":[177],"incidence":[178],"adverse":[180,195],"effects":[181],"was":[182],"13.36%":[183],"patients.":[186,224],"From":[187],"total":[189],"dropouts":[190],"4%":[191],"due":[193],"events.":[196],"CONCLUSIONS:":[197],"is":[199,214],"an":[200],"effective":[201],"safe":[203],"antidepressant":[204],"for":[205],"able":[215],"modify":[217],"somatizing":[223]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W56276121","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
